Search for an orphan drug
Other search option(s)
44 Result(s)
Substance(s)
- (R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate
- 26 base single stranded phosphodiester DNA oligonucleotide
- 4-amino-5-oxo-4 (pyridinium-1-ylmethyl) proline
- Aldesleukin
- Autologous Tumor-Derived gp96 Heat Shock Protein-Peptide Complex
- Autologous renal cell tumor vaccine
- Axitinib
- Bevacizumab
- Everolimus
- Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, in fixed combination with a DNA-based double stem loop immunomodulator (dSLIM)
- Girentuximab
- HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET-MMPMMPMUC-RGS)
- Human interleukin-2 (glycosylated tetrasaccharide, glycosylated trisaccharide and nonglycosylated) (inhalation use)
- Humanized anti-KSA monoclonal antibody-human interleukin-2 fusion protein
- Interferon gamma 1b
- Iodine (131I) chimeric IgG monoclonal antibody cG250
- N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate
- Naptumomab estafenatox
- Pazopanib hydrochloride
- Recombinant human interleukin-21
- Recombinant modified vaccinia Ankara expressing human 5T4
- Siltuximab
- Sorafenib tosylate
- Sunitinib malate
- Talactoferrinum alfa
- Temsirolimus